Berberine improves insulin resistance in cardiomyocytes via activation of 5′-adenosine monophosphate-activated protein kinase

Metabolism: Clinical and Experimental

Volumn 62, Issue 8, 2013, Pages 1159-1167

  Chang, Wenguang ^a   Zhang, Ming ^a   Li, Jing ^a   Meng, Zhaojie ^a   Wei, Shengnan ^a   Du, Hongwei ^b   Chen, Li ^a   Hatch, Grant M ^c  

^a Basic Medical College   (China)

^b JILIN UNIVERSITY   (China)

^c UNIVERSITY OF MANITOBA   (Canada)

Author keywords

AMPK; Berberine; Glucose consumption; H9c2; Insulin resistance

Indexed keywords

5' ADENOSINE MONOPHOSPHATE ACTIVATED PROTEIN KINASE; ADENOSINE PHOSPHATE; BERBERINE; HOE 33342; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL CELL CULTURE; ARTICLE; CELL DIFFERENTIATION; CELL VIABILITY; CONTROLLED STUDY; DRUG MECHANISM; FLUORESCENCE MICROSCOPY; GLUCOSE INTAKE; GLUCOSE TRANSPORT; HEART CELL CULTURE; HEART MUSCLE CELL; INSULIN RESISTANCE; INSULIN SENSITIVITY; MYOBLAST; NONHUMAN; PRIORITY JOURNAL; RAT; WESTERN BLOTTING;

5′-ADENOSINE MONOPHOSPHATE-ACTIVATED PROTEIN KINASE; ADENOSINE MONOPHOSPHATE; AKT; AMP; AMPK; BBR; BERBERINE; DCM; DIABETIC CARDIOMYOPATHY; GLUCOSE CONSUMPTION; GLUCOSE TRANSPORTER-4; GLUT-4; H9C2; INSULIN RECEPTOR SUBSTRATE-1; INSULIN RESISTANCE; IRS-1; PBS; PHOSPHATE BUFFERED SOLUTION; PROTEIN KINASE B(PKB);

AMINOIMIDAZOLE CARBOXAMIDE; AMP-ACTIVATED PROTEIN KINASES; ANIMALS; BENZIMIDAZOLES; BERBERINE; BLOTTING, WESTERN; CELL DIFFERENTIATION; CELL LINE; CELL SURVIVAL; FLUORESCENT DYES; GLUCOSE; HYPOGLYCEMIC AGENTS; INSULIN RESISTANCE; MICROSCOPY, FLUORESCENCE; MYOCYTES, CARDIAC; PROTEIN KINASE INHIBITORS; PROTO-ONCOGENE PROTEINS C-AKT; RATS; RIBONUCLEOTIDES;

EID: 84880572450     PISSN: 00260495     EISSN: 15328600     Source Type: Journal    
DOI: 10.1016/j.metabol.2013.02.007     Document Type: Article

References (37)

1. Y. Minokoshi, T. Alquier, N. Furukawa, Y.B. Kim, A. Lee, and B. Xue AMP-kinase regulates food intake by responding to hormonal and nutrient signals in the hypothalamus Nature 428 6982 2004 569 574
2. S. Yamaguchi, H. Katahira, S. Ozawa, Y. Nakamichi, T. Tanaka, and T. Shimoyama Activators of AMP-activated protein kinase enhance GLUT4 translocation and its glucose transport activity in 3T3-L1 adipocytes Am J Physiol Endocrinol Metab 289 4 2005 E643 E649
3. J. Yin, Z. Gao, D. Liu, Z. Liu, and J. Ye Berberine improves glucose metabolism through induction of glycolysis Am. J. Physiol. Endocrinol. Metab. 294 1 2008 E148 E156
4. M. Foretz, and B. Viollet Regulation of hepatic metabolism by AMPK J Hepatol 54 4 2011 827 829
5. A. Kinote, J.A. Faria, E.A. Roman, C. Solon, D.S. Razolli, and L.M. Ignacio-Souza Fructose-induced hypothalamic AMPK activation stimulates hepatic PEPCK and gluconeogenesis due to increased corticosterone levels Endocrinology 153 8 2012 3633 3645
6. J. Yang, and G.D. Holman Long-term metformin treatment stimulates cardiomyocyte glucose transport through an AMP-activated protein kinase-dependent reduction in GLUT4 endocytosis Endocrinology 147 6 2006 2728 2736
7. C. Wang, J. Li, X. Lv, M. Zhang, Y. Song, and L. Chen Ameliorative effect of berberine on endothelial dysfunction in diabetic rats induced by high-fat diet and streptozotocin Eur J Pharmacol 620 1-3 2009 131 137
8. X. Xia, J. Yan, Y. Shen, K. Tang, J. Yin, and Y. Zhang Berberine improves glucose metabolism in diabetic rats by inhibition of hepatic gluconeogenesis PLoS One 6 2 2011 e16556
9. X. Xie, W. Li, T. Lan, W. Liu, J. Peng, and K. Huang Berberine ameliorates hyperglycemia in alloxan-induced diabetic C57BL/6 mice through activation of Akt signaling pathway Endocr J 58 9 2011 761 768
10. J. Yin, H. Xing, and J. Ye Efficacy of berberine in patients with type 2 diabetes mellitus Metabolism 57 5 2008 712 717
11. Q.M. Chen, and M.Z. Xie Effects of berberine on blood glucose regulation of normal mice Yao Xue Xue Bao 22 3 1987 161 165
12. Z. Cheng, T. Pang, M. Gu, A.H. Gao, C.M. Xie, and J.Y. Li Berberine-stimulated glucose uptake in L6 myotubes involves both AMPK and p38 MAPK Biochim Biophys Acta 1760 11 2006 1682 1689
13. M. Zhang, X. Lv, J. Li, Z. Meng, Q. Wang, and W. Chang Sodium caprate augments the hypoglycemic effect of berberine via AMPK in inhibiting hepatic gluconeogenesis Mol Cell Endocrinol 363 1-2 2012 122 130
14. A. Diestel, C. Drescher, O. Miera, F. Berger, and K.R. Schmitt Hypothermia protects H9c2 cardiomyocytes from H2O2 induced apoptosis Cryobiology 62 1 2011 53 61
15. J. Yin, R. Hu, M. Chen, J. Tang, F. Li, and Y. Yang Effects of berberine on glucose metabolism in vitro Metabolism 51 11 2002 1439 1443
16. W.J. Kong, H. Zhang, D.Q. Song, R. Xue, W. Zhao, and J. Wei Berberine reduces insulin resistance through protein kinase C-dependent up-regulation of insulin receptor expression Metabolism 58 1 2009 109 119
17. Y. Chen, Y. Li, Y. Wang, Y. Wen, and C. Sun Berberine improves free-fatty-acid-induced insulin resistance in L6 myotubes through inhibiting peroxisome proliferator-activated receptor gamma and fatty acid transferase expressions Metabolism 58 12 2009 1694 1702
18. L.Z. Liu, S.C. Cheung, L.L. Lan, S.K. Ho, H.X. Xu, and J.C. Chan Berberine modulates insulin signaling transduction in insulin-resistant cells Mol Cell Endocrinol 317 1-2 2010 148 153
19. M.B.N.S. Hansen, and K. Berg Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill J Immunol Methods 119 1989 203 210
20. H. Sasaki, H. Asanuma, M. Fujita, H. Takahama, M. Wakeno, and S. Ito Metformin prevents progression of heart failure in dogs: role of AMP-activated protein kinase Circulation 119 19 2009 2568 2577
21. A.F. Branco, S.L. Pereira, A.C. Moreira, J. Holy, V.A. Sardao, and P.J. Oliveira Isoproterenol cytotoxicity is dependent on the differentiation state of the cardiomyoblast H9c2 cell line Cardiovasc Toxicol 11 3 2011 191 203
22. S.L. Pereira, J. Ramalho-Santos, A.F. Branco, V.A. Sardao, P.J. Oliveira, and R.A. Carvalho Metabolic remodeling during H9c2 myoblast differentiation: relevance for in vitro toxicity studies Cardiovasc Toxicol 11 2 2011 180 190
23. G.I. Shulman Cellular mechanisms of insulin resistance in humans Am J Cardiol 84 1A 1999 3J 10J
24. G.I. Shulman Cellular mechanisms of insulin resistance J Clin Invest 106 2 2000 171 176
25. J.R. Zierath, A. Krook, and H. Wallberg-Henriksson Insulin action and insulin resistance in human skeletal muscle Diabetologia 43 7 2000 821 835
26. W.H. Chueh, and J.Y. Lin Protective effect of berberine on serum glucose levels in non-obese diabetic mice Int Immunopharmacol 12 3 2012 534 538
27. Y. Hong, S.S. Hui, B.T. Chan, and J. Hou Effect of berberine on catecholamine levels in rats with experimental cardiac hypertrophy Life Sci 72 22 2003 2499 2507
28. B.X. Li, B.F. Yang, J. Zhou, C.Q. Xu, and Y.R. Li Inhibitory effects of berberine on IK1, IK, and HERG channels of cardiac myocytes Acta Pharmacol Sin 22 2 2001 125 131
29. M.Y. Qi, Y. Feng, D.Z. Dai, N. Li, Y.S. Cheng, and Y. Dai CPU86017, a berberine derivative, attenuates cardiac failure through normalizing calcium leakage and downregulated phospholamban and exerting antioxidant activity Acta Pharmacol Sin 31 2 2010 165 174
30. Y.Y. Wang, H.M. Li, H.D. Wang, X.M. Peng, Y.P. Wang, and D.X. Lu Pretreatment with berberine and yohimbine protects against LPS-induced myocardial dysfunction via inhibition of cardiac I-[kappa]B[alpha] phosphorylation and apoptosis in mice Shock 35 3 2011 322 328
31. J.A. Marin-Neto, B.C. Maciel, A.L. Secches, and L. Gallo Junior Cardiovascular effects of berberine in patients with severe congestive heart failure Clin Cardiol 11 4 1988 253 260
32. Y. Hong, S.C. Hui, T.Y. Chan, and J.Y. Hou Effect of berberine on regression of pressure-overload induced cardiac hypertrophy in rats Am. J. Chin. Med. 30 4 2002 589 599
33. W. Chang, M. Zhang, J. Li, Z. Meng, D. Xiao, and S. Wei Berberine attenuates ischemia-reperfusion injury via regulation of adenosine-5'- monophosphate kinase activity in both non-ischemic and ischemic areas of the rat heart Cardiovasc Drugs Ther 26 6 2012 467 478
34. X.Q. Zeng, C.M. Zhang, M.L. Tong, X. Chi, X.L. Li, and C.B. Ji Knockdown of NYGGF4 increases glucose transport in C2C12 mice skeletal myocytes by activation IRS-1/PI3K/AKT insulin pathway J Bioenerg Biomembr 44 3 2012 351 355
35. Y. Nishino, T. Miura, T. Miki, J. Sakamoto, Y. Nakamura, and Y. Ikeda Ischemic preconditioning activates AMPK in a PKC-dependent manner and induces GLUT4 up-regulation in the late phase of cardioprotection Cardiovasc Res 61 3 2004 610 619
36. L. Zhou, Y. Yang, X. Wang, S. Liu, W. Shang, and G. Yuan Berberine stimulates glucose transport through a mechanism distinct from insulin Metabolism 56 3 2007 405 412
37. Y.S. Lee, W.S. Kim, K.H. Kim, M.J. Yoon, H.J. Cho, and Y. Shen Berberine, a natural plant product, activates AMP-activated protein kinase with beneficial metabolic effects in diabetic and insulin-resistant states Diabetes 55 8 2006 2256 2264